Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05008432 · ClinicalTrials.gov registry record
Sleep Apnea in Heart Failure With Preserved Ejection Fraction
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 48
- Enrollment target
NCT05008432: Completed study, sponsored by Mayo Clinic.
NCT05008432 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05008432 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
This is a prospective interventional study to better understand i) the prevalence of Obstructive Sleep Apnea (OSA) in Heart Failure with preserved Ejection Fraction (HFpEF), ii) its hemodynamic correlates, and iii) the impact of intervention with Continuous Positive Airway Pressure (CPAP) on quality of life.
Primary Outcome
Quality of life will be assessed by Kansas City Cardiomyopathy Questionnaire (Scale 0-100)
Interventions
- DIAGNOSTIC_TEST Home sleep apnea testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2024-07-24 |
What the finished NCT05008432 record still lists
NCT05008432 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Home sleep apnea testing is the first listed.
NCT05008432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05008432 about?
NCT05008432 is a clinical study titled "Sleep Apnea in Heart Failure With Preserved Ejection Fraction". This is a prospective interventional study to better understand i) the prevalence of Obstructive Sleep Apnea (OSA) in Heart Failure with preserved Ejection Fraction (HFpEF), ii) its hemodynamic correlates, and iii) the impact of intervention with Continuous Positive Airway Pressure (CPAP) on quality...
What is the current status of trial NCT05008432?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2021-10-07. Estimated completion is 2024-07-24.
What interventions are being tested in trial NCT05008432?
The interventions under investigation include: Home sleep apnea testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05008432?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI